I sent an email to Leo asking about the PR from l
Post# of 72446
Posted On: 01/29/2014 10:37:20 AM
I sent an email to Leo asking about the PR from last year regarding CTIX collaborating with a NYC clinical research center (Sloan-Kettering?) about a new drug (see question below).
Just received the following email from him.
Also, nice touch leaving Biomanbaba as an asst mod. I am sure he is keeping close tabs on one of his Magnificent Seven.
During further due diligence questions came up which the hospital said they are working on to provide answers to us (or others) . We haven't been pushing this project but will soon revisit it.
Best wishes,
Leo Ehrlich
On Thu, Jan 23, 2014 at 9:01 PM, Pete <petemantx@charter.net> wrote:
Is the CDA still in effect and progress being made regarding the PR that is referenced above? I am led to believe it is Memorial Sloan-Kettering though I realize you can’t name them and the PR says that Dr Danishefsky brought the drug to your attention. Again makes me wonder if it is a drug he brought into existence (just a statement, not a question). I realize after the PolyMedix purchase (major kudos for IMO it seems this is a business coup that should be discussed in MBA classes to highlight the degree of professionalism shown to acquire an asset of great value for next to nothing) that CTIX has more products to work with then time to look at most of them within 5 years or more and you and Dr Menon realized CTIX didn’t have the manpower or finances to pursue this avenue (unless the NYC partner is financing the additional testing).
Thanks
Just received the following email from him.
Also, nice touch leaving Biomanbaba as an asst mod. I am sure he is keeping close tabs on one of his Magnificent Seven.
During further due diligence questions came up which the hospital said they are working on to provide answers to us (or others) . We haven't been pushing this project but will soon revisit it.
Best wishes,
Leo Ehrlich
On Thu, Jan 23, 2014 at 9:01 PM, Pete <petemantx@charter.net> wrote:
Is the CDA still in effect and progress being made regarding the PR that is referenced above? I am led to believe it is Memorial Sloan-Kettering though I realize you can’t name them and the PR says that Dr Danishefsky brought the drug to your attention. Again makes me wonder if it is a drug he brought into existence (just a statement, not a question). I realize after the PolyMedix purchase (major kudos for IMO it seems this is a business coup that should be discussed in MBA classes to highlight the degree of professionalism shown to acquire an asset of great value for next to nothing) that CTIX has more products to work with then time to look at most of them within 5 years or more and you and Dr Menon realized CTIX didn’t have the manpower or finances to pursue this avenue (unless the NYC partner is financing the additional testing).
Thanks
(0)
(0)